We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 47.99%
This Fund
S&P 500
This Quarter Est. Return
-1.51%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
AUM
$1.37B
AUM Growth
-$35.7M
Cap. Flow
+$25.6M
Cap. Flow %
1.87%
Top 10 Hldgs %
88.69%
Holding
27
New
6
Increased
8
Reduced
4
Closed

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$10.7M
2
GIS icon
General Mills
GIS
+$9.98M
3
HLF icon
Herbalife
HLF
+$4.53M
4
SHC icon
Sotera Health
SHC
+$4.34M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.19M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.09M
2
BNTX icon
BioNTech
BNTX
+$1.32M

Sector Composition

Rank Sector Weight
1 Financials 18.73%
2 Communication Services 10.98%
3 Consumer Staples 10.05%
4 Healthcare 6.5%
5 Materials 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
1
CALL
iShares Russell 2000 ETF
IWM
$79.8B
$344M 25.18%
156,100
+11,700
+8% +$2.59M
SPY icon
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$183M 13.36%
42,400
-9,900
-19% -$4.37M
IWO icon
3
CALL
iShares Russell 2000 Growth ETF
IWO
$14.3B
$136M 9.94%
462,700
-56,800
-11% -$17.1M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.36T
$131M 9.62%
983,520
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.1T
$114M 8.32%
416,558
-7,435
-2% -$2.09M
HLF icon
6
Herbalife
HLF
$1.29B
$99.4M 7.27%
2,345,486
+91,625
+4% +$4.53M
REGN icon
7
Regeneron Pharmaceuticals
REGN
$78.5B
$75.2M 5.5%
124,224
+6,755
+6% +$4.19M
IBKR icon
8
Interactive Brokers
IBKR
$39.2B
$54.2M 3.96%
3,474,900
+66,252
+2% +$1.04M
V icon
9
Visa
V
$684B
$39.5M 2.89%
177,440
CTVA icon
10
Corteva
CTVA
$52.6B
$36.2M 2.65%
859,996
+36,754
+4% +$1.59M
BNY
11
Bank of New York Mellon
BNY
$106B
$25.8M 1.89%
497,891
STT icon
12
State Street
STT
$50.6B
$22.8M 1.66%
268,574
GOOG icon
13
Alphabet (Google) Class C
GOOG
$4.36T
$18.6M 1.36%
139,440
GHC icon
14
Graham Holdings Company
GHC
$5.1B
$15M 1.09%
25,399
+1,906
+8% +$1.19M
MO icon
15
Altria Group
MO
$114B
$13.1M 0.96%
287,561
BYND icon
16
PUT
Beyond Meat
BYND
$292M
$10.5M 0.77%
100,000
GIS icon
17
General Mills
GIS
$19.1B
$10.1M 0.74%
+168,870
New +$9.98M
PM icon
18
Philip Morris
PM
$297B
$10.1M 0.74%
+106,293
New +$10.7M
SHC icon
19
Sotera Health
SHC
$5.09B
$4.69M 0.34%
+179,279
New +$4.34M
MDLZ icon
20
Mondelez International
MDLZ
$79.5B
$4.64M 0.34%
79,715
+9,908
+14% +$616K
NEM icon
21
Newmont
NEM
$98.7B
$3.96M 0.29%
72,921
+92
+0.1% +$5.42K
BBWI icon
22
Bath & Body Works
BBWI
$4.06B
$3.77M 0.28%
+59,794
New +$3.8M
VIR icon
23
Vir Biotechnology
VIR
$1.46B
$3.26M 0.24%
+74,920
New +$3.24M
MACK
24
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2.65M 0.19%
548,836
NPO icon
25
Enpro
NPO
$6.63B
$2.61M 0.19%
+30,000
New +$2.63M

Similar funds

Bronte Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Bronte Capital Management held 27 positions worth $1.37B, down 2.5% from $1.4B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Bronte Capital Management's Q3 2021 filing shows 6 new, 8 increased and 4 reduced positions. Its largest new stake was Philip Morris: 106,293 shares worth $10.1M. The largest sale was Berkshire Hathaway Class B, an estimated $2.09M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Communication Services and Consumer Staples.

  • Bronte Capital Management's largest Q3 2021 buy was Philip Morris: 106,293 shares worth $10.1M.
  • Bronte Capital Management added most to Herbalife in Q3 2021, an estimated $4.53M increase.
  • Bronte Capital Management's biggest Q3 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $2.09M.
  • Bronte Capital Management's ten largest holdings make up 89% of its $1.37B portfolio in Q3 2021.
  • Bronte Capital Management opened 6 new positions and closed 0 in Q3 2021.
  • Bronte Capital Management's portfolio value fell 2.5% quarter-over-quarter to $1.37B.

Based on Bronte Capital Management's 13F filing for Q3 2021, filed 9 Nov 2021.